Timothy W. Schacker

Active 1996–2025

86
Papers
22,257
Citations
67
h-index
83
i10-index

Citations

Citations per year for Timothy W. Schacker1988: 1 citations1994: 2 citations1997: 18 citations1998: 44 citations1999: 54 citations2000: 90 citations2001: 97 citations2002: 118 citations2003: 90 citations2004: 102 citations2005: 97 citations2006: 123 citations2007: 226 citations2008: 240 citations2009: 215 citations2010: 255 citations2011: 283 citations2012: 244 citations2013: 286 citations2014: 223 citations2015: 183 citations2016: 256 citations2017: 189 citations2018: 157 citations2019: 741 citations2020: 649 citations2021: 616 citations2022: 427 citations2023: 288 citations2024: 417 citations2025: 208 citations2026: 5 citations1989–1993: no citations, so these years are not shown1995–1996: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,185 citing papers, 40.5% of this breakdownUnited Kingdom: 493 citing papers, 6.3% of this breakdownCanada: 385 citing papers, 4.9% of this breakdownChina: 324 citing papers, 4.1% of this breakdownFrance: 302 citing papers, 3.8% of this breakdownAustralia: 297 citing papers, 3.8% of this breakdownGermany: 273 citing papers, 3.5% of this breakdownItaly: 264 citing papers, 3.4% of this breakdownSpain: 200 citing papers, 2.5% of this breakdownSwitzerland: 193 citing papers, 2.5% of this breakdownSouth Africa: 192 citing papers, 2.4% of this breakdownNetherlands: 184 citing papers, 2.3% of this breakdown
0%40.5%Other 20%

Fields

  • Immunology and Microbiology57.6%
  • Medicine31.7%
  • Biochemistry, Genetics and Molecular Biology7.4%
  • Neuroscience1.2%
  • Agricultural and Biological Sciences0.4%
  • Computer Science0.2%
  • Other1.5%

Topics

  • HIV Research and Treatment18.9%
  • Immune Cell Function and Interaction10.7%
  • HIV/AIDS Research and Interventions7.1%
  • T-cell and B-cell Immunology5.2%
  • HIV/AIDS drug development and treatment5.1%
  • HIV-related health complications and treatments4.3%
  • Other48.7%

Coauthors

All papers

Open in search
  1. HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation

    Authors: , , , , , , , , , , , , , , , - Nature Medicine 2009 cited by 1,730

  2. Microbial translocation is a cause of systemic immune activation in chronic HIV infection

    Authors: , , , , , , , , , , , , , , , , , , , - Nature Medicine 2006 cited by 3,542

  3. CXCR5+ follicular cytotoxic T cells control viral infection in B cell follicles

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Di Wu, Marc Pellegrini, Yew Ann Leong, Heather M. Long, Jesse G. Toe, Yong Tao, Meinrad Busslinger - Nature Immunology 2016 cited by 485

  4. Defining total-body AIDS-virus burden with implications for curative strategies

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ashley T. Haase, Timothy W. Schacker - Nature Medicine 2017 cited by 416

  5. Persistent HIV-1 replication is associated with lower antiretroviral drug concentrations in lymphatic tissues

    Authors: , , , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2014 cited by 655

  6. Safety and virologic impact of the IL-15 superagonist N-803 in people living with HIV: a phase 1 trial

    Authors: , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2022 cited by 107

  7. CD4+ T Cell Depletion during all Stages of HIV Disease Occurs Predominantly in the Gastrointestinal Tract

    Authors: , , , , , , , , , , - The Journal of Experimental Medicine 2004 cited by 1,818

  8. Persistent HIV-1 replication maintains the tissue reservoir during therapy

    Authors: , , , , , , , , , , , , , , , - Nature 2016 cited by 631

  9. Recommendations for analytical antiretroviral treatment interruptions in HIV research trials—report of a consensus meeting

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jessica Salzwedel, Karl Salzwedel, Timothy W. Schacker, Virginia Sheikh, Ole S. Søgaard, Serena Spudich, Kathryn E. Stephenson, Jeremy Sugarman, Jeff Taylor, Pablo Tebas, Caroline T. Tiemessen, Randall Tressler, Carol D. Weiss, Lu Zheng, Merlin L. Robb, Nelson L. Michael, John W. Mellors, Steven G. Deeks, Bruce D. Walker - The Lancet HIV 2019 cited by 206

  10. High-affinity memory B cells induced by SARS-CoV-2 infection produce more plasmablasts and atypical memory B cells than those primed by mRNA vaccines

    Authors: , , , , , , , , , , , , , , , - Cell Reports 2021 cited by 112

  11. PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection

    Authors: , , , , , , , , , , - The Journal of Experimental Medicine 2006 cited by 875

  12. Defining HIV and SIV Reservoirs in Lymphoid Tissues

    Authors: , , , , , , , , , , , , , , - Pathogens and Immunity 2016 cited by 262

  13. Translocated microbiome composition determines immunological outcome in treated HIV infection

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Cissy Kityo, Jason M. Brenchley, Timothy W. Schacker, Rafick‐Pierre Sékaly, Daniel C. Douek - Cell 2021 cited by 80

  14. Large number of rebounding/founder HIV variants emerge from multifocal infection in lymphatic tissues after treatment interruption

    Authors: , , , , , , , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2015 cited by 278

  15. IL-15 promotes activation and expansion of CD8+ T cells in HIV-1 infection

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Investigation 2016 cited by 120

  16. Abundant HIV-infected cells in blood and tissues are rapidly cleared upon ART initiation during acute HIV infection

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , on behalf of the RV254/SEARCH010, RV304/SEARCH013, SEARCH011 study groups - Science Translational Medicine 2020 cited by 108

  17. Challenges in Detecting HIV Persistence during Potentially Curative Interventions: A Study of the Berlin Patient

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - PLoS Pathogens 2013 cited by 290

  18. Multiple Origins of Virus Persistence during Natural Control of HIV Infection

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Cell 2016 cited by 183

  19. Differential Th17 CD4 T-cell depletion in pathogenic and nonpathogenic lentiviral infections

    Authors: , , , , , , , , , , , , , , , - Blood 2008 cited by 634

  20. Pirfenidone ameliorates murine chronic GVHD through inhibition of macrophage infiltration and TGF-β production

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Blood 2017 cited by 156

  21. Time to HIV viral rebound and frequency of post-treatment control after analytical interruption of antiretroviral therapy: an individual data-based meta-analysis of 24 prospective studies

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Communications 2025 cited by 52

  22. Interferon-α Is the Primary Plasma Type-I IFN in HIV-1 Infection and Correlates with Immune Activation and Disease Markers

    Authors: , , , , , , , , , , , , , - PLoS ONE 2013 cited by 167

  23. Cumulative mechanisms of lymphoid tissue fibrosis and T cell depletion in HIV-1 and SIV infections

    Authors: , , , , , , , , , , , - Journal of Clinical Investigation 2011 cited by 304

  24. Lymphoid Tissue Damage in HIV-1 Infection Depletes Naïve T Cells and Limits T Cell Reconstitution after Antiretroviral Therapy

    Authors: , , , , , , - PLoS Pathogens 2012 cited by 176